Regeneron Pharmaceuticals, Inc.
ANGPTL8 ASSAY AND USES THEREOF
Last updated:
Abstract:
The present invention provides ELISA-based methods for detecting and/or quantifying ANGPTL8 in biological samples using anti-ANGPTL8 antibodies.
Status:
Application
Type:
Utility
Filling date:
18 Dec 2018
Issue date:
17 Dec 2020